We are live on ! Find out more
TWST icon

Twist Bioscience

245 hedge funds and large institutions have $2.99B invested in Twist Bioscience in 2024 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 92 increasing their positions, 77 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

193% more call options, than puts

Call options by funds: $5.94M | Put options by funds: $2.02M

19% more repeat investments, than reductions

Existing positions increased: 92 | Existing positions reduced: 77

0.55% less ownership

Funds ownership: 113.33%112.78% (-0.55%)

6% less funds holding

Funds holding: 262245 (-17)

8% less capital invested

Capital invested by funds: $3.25B → $2.99B (-$264M)

32% less first-time investments, than exits

New positions opened: 34 | Existing positions closed: 50

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
245
Holders Change
-17
Holders Change %
-6.49%
% of All Funds
3.52%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
34
Increased
92
Reduced
77
Closed
50
Calls
$5.94M
Puts
$2.02M
Net Calls
+$3.91M
Net Calls Change
-$1.05M
Name Holding Trade Value Shares
Change
Change in
Stake
XT
126
XTX Topco
Cayman Islands
$701K +$198K +4,169 +37%
PI
127
PEAK6 Investments
Illinois
$678K -$119K -2,500 -14%
ProShare Advisors
128
ProShare Advisors
Maryland
$666K +$142K +2,990 +25%
Teacher Retirement System of Texas
129
Teacher Retirement System of Texas
Texas
$660K +$90.6K +1,905 +15%
SGA
130
Seaport Global Advisors
Massachusetts
$642K -$82.6K -1,737 -11%
GCM
131
Graham Capital Management
Connecticut
$630K -$3.28K -69 -0.5%
DTL
132
Dynamic Technology Lab
Singapore
$599K +$630K +13,248 New
BEI
133
Benjamin Edwards Inc
Missouri
$572K +$597K +12,549 +10,120%
Balyasny Asset Management
134
Balyasny Asset Management
Illinois
$560K -$2.92M -61,430 -83%
Los Angeles Capital Management
135
Los Angeles Capital Management
California
$551K +$89.8K +1,888 +18%
VA
136
Vident Advisory
Georgia
$532K -$222K -4,665 -28%
CUAMC
137
China Universal Asset Management Company
China
$509K +$211K +4,427 +65%
IP
138
Isthmus Partners
Wisconsin
$504K
SG Americas Securities
139
SG Americas Securities
New York
$495K +$419K +8,797 +407%
CAM
140
Concorde Asset Management
Michigan
$493K -$23.6K -495 -4%
IEFM
141
IQ EQ Fund Management
Ireland
$482K +$119K +2,505 +31%
FRM
142
Fox Run Management
Connecticut
$479K +$38.6K +812 +8%
Osaic Holdings
143
Osaic Holdings
Arizona
$465K -$915K -19,231 -65%
PFM
144
Premier Fund Managers
United Kingdom
$455K
GAA
145
Green Alpha Advisors
Colorado
$425K -$153K -3,225 -26%
SW
146
SteelPeak Wealth
California
$416K +$438K +9,212 New
D.E. Shaw & Co
147
D.E. Shaw & Co
New York
$409K +$237K +4,971 +122%
AIM
148
Aigen Investment Management
New York
$408K +$196K +4,125 +84%
VIA
149
Virtus Investment Advisers
Connecticut
$407K
EFM
150
E Fund Management
China
$404K +$127K +2,677 +43%

TWST Hedge Fund Activity: Q3 2024 in Review

245 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Twist Bioscience (TWST) for Q3 2024, worth a combined $2.99B — down 8.1% from $3.25B a quarter earlier.

Sellers outnumbered buyers: 50 funds closed out of TWST and 34 opened new positions — a net loss of 16 holders — while 77 trimmed existing stakes and 92 added.

The largest buyer was Thrivent Financial for Lutherans, opening a new position worth an estimated $46.3M. The largest seller was ARK Investment Management, cutting an estimated $36.7M.

  • 245 institutional investors held Twist Bioscience (TWST) as of Q3 2024, down from 262 in Q2 2024.
  • Funds reported $2.99B of Twist Bioscience stock for Q3 2024, down 8.1% quarter-over-quarter.
  • 34 funds opened new Twist Bioscience positions in Q3 2024 and 50 closed out, a net change of -16 holders.
  • The largest Twist Bioscience buyer in Q3 2024 was Thrivent Financial for Lutherans, an estimated $46.3M added.
  • The largest Twist Bioscience seller in Q3 2024 was ARK Investment Management, an estimated $36.7M sold.

Based on aggregated 13F filings for Q3 2024.